Agreement combines Givaudan Active Beauty ingredients with Brenntag’s local distribution network and formulation support across both markets IN BRIEFKEY TAKEAWAYSFAQs Brenntag has expanded its distribution agreement with Givaudan to cover Australia and New Zealand, giving beauty and personal care manufacturers … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Chemicals, Industrial
Tagged Asia-Pacific, Australia, Beauty Care, Bonwook Koo, Brenntag, Brenntag and Givaudan Strengthen Asia Pacific Beauty Collaboration with New Markets, Brenntag Expands Beauty Ingredients Distribution Agreement with Givaudan Across Oceania, Cosmetic active ingredients, Cosmetics distribution, Expanded Brenntag Agreement Adds Local Formulation Support for Givaudan Beauty Ingredients, formulation development, Givaudan, Givaudan Active Beauty, Givaudan Active Beauty Portfolio Reaches Australian and New Zealand Manufacturers Through Brenntag, Innovation & Application Centers, Malaysia, New Zealand, Personal care manufacturing, Singapore, specialty ingredients, THAILAND, Vietnam, Wissanee Ruangsorn
(IN BRIEF) Brenntag Pharma has entered into an exclusive distribution partnership with Indovinya Belgium N.V., part of the Indorama Group, for Oxipurity® polyethylene glycols and polysorbates used in pharmaceutical and nutraceutical applications across France, Italy, Belgium, the Netherlands, Denmark, Finland, … Read the full press release
Posted in Belgium, Business, Chemicals, Denmark, Finland, France, Italy, Netherlands, Norway, Pharma & Biotech, Sweden
Tagged ANVISA, Belgium, Brenntag, Brenntag and Indovinya Expand European Pharmaceutical Partnership With Exclusive Excipient Distribution Agreement, Brenntag Pharma, Brenntag Pharma Strengthens Formulation Offering With Indovinya Oxipurity® Polyethylene Glycols and Polysorbates, Brenntag Secures Exclusive European Distribution Rights for Indovinya Oxipurity® Excipients in Key Pharma Markets, Denmark, EP, Europe, European Pharmacopoeia, EXCiPACT, exclusive distribution agreement, Fabiana Citraro Marra, Finland, formulation development, France, GMP, Good Manufacturing Practices, hard capsules, Indorama Group, Indovinya, Indovinya Belgium N.V., ingredient distribution, IPEC-PQG, Italy, Joakim Rehné, Macrogols, Netherlands, non-ionic surfactants, Norway, nutraceutical excipients, nutraceutical formulations, oral liquids, Oxipurity, Oxipurity 4000, Oxipurity 7080, PEGs, pharmaceutical excipients, pharmaceutical formulations, pharmaceutical ingredients, Polyethylene glycols, polysorbates, regulatory compliance, soft capsules, specialty chemicals, suppositories, Sweden, tablets, topical preparations, United States Pharmacopeia, USP
(IN BRIEF) Evonik is investing more than CAD 150 million, or approximately EUR 93 million, in a new GMP drug product manufacturing facility for lipid-based drug delivery in Vancouver, Canada, supported by up to CAD 68 million, or around EUR … Read the full press release
Posted in Business, Chemicals, Germany, Government, Healthcare, Industrial, Investment, Pharma & Biotech, Science, Technology
Tagged 2034, adjuvant supply, advanced medicines, biotech ecosystem, Birmingham Alabama, British Columbia, CAD 150 million, CAD 68 million, Cambridge Innovation Satellite, CANADA, Canada Economic Development for Quebec Regions, Canadian federal government, CDMO services, clinical manufacturing, commercial process scale-up, commercial scale, Custom Solutions, Dossenheim, drug product manufacturing, end of 2029 production, equipment engineering, EUR 42 million, EUR 93 million, Evonik, Evonik Expands Lipid-Based Drug Delivery Capacity With New Vancouver GMP Facility, Evonik Health Care, Evonik Invests CAD 150 Million in Vancouver LNP Manufacturing Expansion, Evonik Vancouver Laboratories, formulation development, formulation research, Germany, GMP manufacturing facility, good manufacturing practice, Greater Boston, Greater Vancouver, Guido Skudlarek, Hanau, highly skilled jobs, Lafayette Indiana, Lauren Kjeldsen, life sciences innovation, lipid chemistry, lipid nanoparticles, lipid-based drug delivery, liposomal delivery systems, LNP, Mélanie Joly, microbiological testing, mRNA, New Evonik GMP Facility to Support Lipid Nanoparticle Drug Development and Manufacturing, Northern Lipids, nucleic acid therapeutics, parenteral drugs, pharmaceutical manufacturing, process engineering, QC, quality control, regulatory know-how, sterile manufacturing, Strategic Response Fund, therapeutics, Tippecanoe Labs, Transferra Nanosciences, University of British Columbia, USD 2.7 billion market forecast, vaccines, Vancouver
(IN BRIEF) GEA has launched the ConsiGma® FC Lab tablet coater at Interpack 2026, introducing a laboratory-scale coating system designed for small pharmaceutical tablet batches ranging from 0.5 to 1.5 kilograms. The system expands GEA’s ConsiGma® coating portfolio and integrates … Read the full press release
Posted in Business, Financial, Food & Beverage, Germany, Industrial, Investment, Management, Marketing, Pharma & Biotech, Technology
Tagged active pharmaceutical ingredients, AirConnect platform, Animal Health, API, coating technology, ConsiGma FC Lab, ConsiGma® FC Lab Enables Faster and More Efficient Tablet Coating for Pharmaceutical Research Teams, drug development, enteric coating, fluid bed systems, formulation development, GEA, GEA Launches Laboratory-Scale Tablet Coating System Designed to Accelerate Drug Development, Interpack 2026, laboratory-scale coating, Mark Rowland, nutraceuticals, pharmaceutical manufacturing, pharmaceutical processing, pharmaceutical R&D, process optimization, solid dosage, tablet coater, tablet coating
(IN BRIEF) Evonik and Higuchi Inc. have launched a new joint laboratory in Yokohama, Japan, to advance oral drug delivery innovation and support pharmaceutical companies with localized technical expertise. The Open Pharma Lab will provide access to Evonik’s EUDRAGIT® polymers … Read the full press release
Posted in Business, Chemicals, Germany, Industrial, Investment, Management, Pharma & Biotech
Tagged Asia market, biotechnology, drug delivery, EUDRAGIT® Polymers, Evonik expands Asia innovation network with new Yokohama lab in partnership with Higuchi, Evonik Industries, excipients, formulation development, Guido Skudlarek, Healthcare, Higuchi Inc, Open Pharma Lab, pharmaceutical innovation, Wataru Ohama, Yokohama Japan
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?